Abstract
The analysis of extensive electronic health records (EHR) datasets often calls for automated solutions, with machine learning (ML) techniques, including deep learning (DL), taking a lead role. One common task involves categorizing EHR data into predefined groups. However, the vulnerability of EHRs to noise and errors stemming from data collection processes, as well as potential human labeling errors, poses a significant risk. This risk is particularly prominent during the training of DL models, where the possibility of overfitting to noisy labels can have serious repercussions in healthcare. Despite the well-documented existence of label noise in EHR data, few studies have tackled this challenge within the EHR domain. Our work addresses this gap by adapting computer vision (CV) algorithms to mitigate the impact of label noise in DL models trained on EHR data. Notably, it remains uncertain whether CV methods, when applied to the EHR domain, will prove effective, given the substantial divergence between the two domains. We present empirical evidence demonstrating that these methods, whether used individually or in combination, can substantially enhance model performance when applied to EHR data, especially in the presence of noisy/incorrect labels. We validate our methods and underscore their practical utility in real-world EHR data, specifically in the context of COVID-19 diagnosis. Our study highlights the effectiveness of CV methods in the EHR domain, making a valuable contribution to the advancement of healthcare analytics and research.
Competing Interest Statement
DAC reports personal fees from Oxford University Innovation, personal fees from BioBeats, personal fees from Sensyne Health, outside the submitted work. MP and HT are employees at Exscientia.
Funding Statement
This work was supported by the Wellcome Trust/University of Oxford Medical & Life Sciences Translational Fund (Award: 0009350), and the Oxford National Institute of Research (NIHR) Biomedical Research Centre (BRC). JY is a Marie Sklodowska-Curie Fellow, under the European Union Horizon 2020 research and innovation programme (Grant agreement: 955681, MOIRA). AAS is an NIHR Academic Clinical Fellow (Award: ACF-2020-13-015). DAC was supported by a Royal Academy of Engineering Research Chair, an NIHR Research Professorship, the InnoHK Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE), and the Pandemic Sciences Institute at the University of Oxford. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
United Kingdom National Health Service (NHS) approval via the national oversight/regulatory body, the Health Research Authority (HRA), has been granted for use of routinely collected clinical data to develop and validate artificial intelligence models to detect Covid-19 (CURIAL; NHS HRA IRAS ID: 281832).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
{jenny.yang{at}eng.ox.ac.uk,david.clifton{at}eng.ox.ac.uk}, {htriendl{at}exscientia.co.uk,mprakash{at}exscientia.co.uk}, andrew.soltan{at}oncology.ox.ac.uk
↵† Shared last authors
